Teratoma clinical trials

The registry lists 73 studies for Teratoma across more than 10 countries. 7 are recruiting or about to start. 12 of them are mainly about Teratoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its narrower condition Teratoma, Testicular too: 76 studies, 7 open.

Get an email when these change. Save the Teratoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 53
Status unknown: 7
Recruiting: 6
Terminated: 4
Not yet recruiting: 1
Withdrawn: 1

Phase

Phase 2: 27
Phase 3: 15
Phase 1: 14

Where

United States: 52
United Kingdom: 11
Canada: 10
Australia: 9
France: 7
Switzerland: 6

Who runs them

Children's Oncology Group (10) · Memorial Sloan Kettering Cancer Center (8) · National Cancer Institute (NCI) (7) · Fred Hutchinson Cancer Center (7) · Children's Cancer and Leukaemia Group (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · National Institutes of Health Clinical Center (CC) (3) · West China Hospital (2)

What is being tested here

Drugs under test in Teratoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Etoposide	1	4	13
Carboplatin	1	2	10
Cisplatin	1	3	8
Thiotepa	1	0	5
Bleomycin	1	2	5
Ifosfamide	0	2	9
Paclitaxel	0	3	9
Filgrastim	0	0	4
Etoposide phosphate	0	1	2
Oxaliplatin	0	1	2

Drug classes tested here Alkylating agents 1 open · Antimitotic agents 12

Coming up

2phase 3 studies under way

3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Jun 2027Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors · Phase 3 · Children's Oncology Group
Jun 2027Subxiphoid VATS for Giant Mediastinal Teratoma · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Jun 2027Molecular Epidemiology of Pediatric Germ Cell Tumors · Children's Oncology Group

Who these studies take

Of the 6 Teratoma studies recruiting now, 4 (67%) set no upper age limit and 2 (33%) stop at 75 or younger. 5 (83%) take children under 18. 0 (0%) are for women only and 1 (17%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	5 (83%)	5 (83%)
18	5 (83%)	6 (100%)
30	3 (50%)	4 (67%)
40	3 (50%)	4 (67%)
50	3 (50%)	4 (67%)
65	3 (50%)	4 (67%)
75	3 (50%)	4 (67%)
85	3 (50%)	4 (67%)

Across all 73 studies, recruiting or not: 52% stop at 75 or younger and 45% at 65; 78% take children; 0% are for women only and 18% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.